A targeted method for standardized assessment of adverse drug events in surgical patients

Journal of Evaluation in Clinical Practice

Volumn 19, Issue 6, 2013, Pages 1073-1082

  De Boer, Monica ^a   Kiewiet, Jordy J S ^a   Boeker, Eveline B ^a   Ramrattan, Maya A ^b   Dijkgraaf, Marcel G W ^a   Lie A Huen, Loraine ^a   Boermeester, Marja A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Maasstad Hospital   (Netherlands)

Author keywords

adverse drug event; causality assessment, surgical patient; trigger tool

Indexed keywords

AMIKACIN; AMIODARONE; ANTIDIARRHEAL AGENT; ANTIHISTAMINIC AGENT; CARBAMAZEPINE; CYCLOSPORIN; DESMOPRESSIN; DIGOXIN; EMETIC AGENT; FLUCYTOSINE; FLUMAZENIL; GENTAMICIN; GLUCOSE; LITHIUM; NALOXONE; NORADRENALIN; PHENOBARBITAL; PHENYTOIN; POLYSTYRENESULFONATE CALCIUM; POLYSTYRENESULFONATE SODIUM; PROCAINAMIDE; PROTAMINE; QUINIDINE SULFATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TOBRAMYCIN; TRANEXAMIC ACID; UNINDEXED DRUG; VALPROIC ACID; VANCOMYCIN; VITAMIN K GROUP;

ADVERSE DRUG REACTION; ANAPHYLACTIC SHOCK; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COHORT ANALYSIS; CONSULTATION; DISEASE SEVERITY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OTOTOXICITY; OUTCOME ASSESSMENT; PHARMACIST; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RELIABILITY; STANDARDIZATION; SURGEON; SURGICAL PATIENT;

ADVERSE DRUG EVENT; CAUSALITY ASSESSMENT, SURGICAL PATIENT; TRIGGER TOOL;

CAUSALITY; CLINICAL PROTOCOLS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HOSPITALIZATION; HUMANS; MEDICATION ERRORS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SURGICAL PROCEDURES, OPERATIVE;

EID: 84888311559     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12033     Document Type: Article

References (44)

1. Leape, L. L., Brennan, T. A., Laird, N., Lawthers, A. G., Localio, A. R., Barnes, B. A., Hebert, L., Newhouse, J., Weiler, P. C., &, Hiatt, H., (1991) The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. The New England Journal of Medicine, 324, 377-384.
2. Morimoto, T., Gandhi, T. K., Seger, A. C., Hsieh, T. C., &, Bates, D. W., (2004) Adverse drug events and medication errors: detection and classification methods. Quality & Safety in Health Care, 13, 306-314.
3. Cano, F. G., &, Rozenfeld, S., (2009) Adverse drug events in hospitals: a systematic review. Cadernos De Saúde Pública, 25, 360-372.
4. De Vries, E. N., Ramrattan, M. A., Smorenburg, S. M., Gouma, D. J., &, Boermeester, M. A., (2008) The incidence and nature of in-hospital adverse events: a systematic review. Quality & Safety in Health Care, 17, 216-223.
5. Kennedy, J. M., van Rij, A. M., Spears, G. F., Pettigrew, R. A., &, Tucker, I. G., (2000) Polypharmacy in a general surgical unit and consequences of drug withdrawal. British Journal of Clinical Pharmacology, 49, 353-362.
6. Bates, D. W., Miller, E. B., Cullen, D. J., et al. (1999) Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Archives of Internal Medicine, 159, 2553-2560.
7. Kanjanarat, P., Winterstein, A. G., Johns, T. E., Hatton, R. C., Gonzalez-Rothi, R., &, Segal, R., (2003) Nature of preventable adverse drug events in hospitals: a literature review. American Journal of Health-System Pharmacy, 60, 1750-1759.
8. Nagpal, K., Vats, A., Lamb, B., Ashrafian, H., Sevdalis, N., Vincent, C., &, Moorthy, K., (2010) Information transfer and communication in surgery: a systematic review. Annals of Surgery, 252, 225-239.
9. Barajas-Nava, L., Solà, I., Delgado-Noguera, M., Gich, I., Villagran, C. O., Bonfill, X., &, Alonso-Coello, P., (2010) Quality assessment of clinical practice guidelines in perioperative care: a systematic appraisal. Quality & Safety in Health Care, 19, e50.
10. Classen, D. C., Pestotnik, S. L., Evans, R. S., &, Burke, J. P., (1991) Computerized surveillance of adverse drug events in hospital patients. The Journal of the American Medical Association, 266, 2847-2851.
11. Jha, A. K., Kuperman, G. J., Teich, J. M., Leape, L., Shea, B., Rittenberg, E., Burdick, E., Seger, D. L., Vander Vliet, M., &, Bates, D. W., (1998) Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. Journal of the American Medical Informatics Association, 5, 305-314.
12. Meyer-Massetti, C., Cheng, C. M., Schwappach, D. L. B., Paulsen, L., Ide, B., Meier, C. R., &, Guglielmo, B. J., (2011) Systematic review of medication safety assessment methods. American Journal of Health-System Pharmacy, 68, 227-240.
13. Jick, H., (1974) Drugs-remarkably nontoxic. The New England Journal of Medicine, 291, 824-828.
14. Resar, R. K., Rozich, J. D., &, Classen, D., (2003) Methodology and rationale for the measurement of harm with trigger tools. Quality & Safety in Health Care, 12, 39-45.
15. Griffin, F. A., &, Resar, R. K., (2009) IHI Global Trigger Tool for Measuring Adverse Events. 2nd edn. IHI Innovation Series White Paper. Cambridge, MA: Institute for Healthcare Improvement.
16. Gurwitz, J. H., Field, T. S., Judge, J., et al. (2005) The incidence of adverse drug events in two large academic long-term care facilities. The American Journal of Medicine, 118, 251-258.
17. Bennett-Guerrero, E., Welsby, I., Dunn, T. J., Young, L. R., Wahl, T. A., Diers, T. L., Phillips-Bute, B. G., Newman, M. F., &, Mythen, M. G., (1999) The use of a postoperative morbidity survey to evaluate patients with prolonged hospitalization after routine, moderate-risk, elective surgery. Anesthesia and Analgesia, 89, 514-519.
18. Zegers, M., De Bruijne, M. C., De Keizer, B., Merten, H., Groenewegen, P. P., Van der Wal, G., &, Wagner, C., (2011) The incidence, root-causes, and outcomes of adverse events in surgical units: implication for potential prevention strategies. Patient Safety in Surgery, 5, 13.
19. Rozich, J. D., Haraden, C. R., &, Resar, R. K., (2003) Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Quality & Safety in Health Care, 12, 194-200.
20. Griffin, F. A., &, Classen, D. C., (2008) Detection of adverse events in surgical patients using the trigger tool approach. Quality & Safety in Health Care, 17, 253-258.
21. Agbabiaka, T. B., Savovic̈, J., &, Ernst, E., (2008) Methods for causality assessment of adverse drug reactions: a systematic review. Drug Safety, 31, 21-37.
22. De Boer, M., Ramrattan, M. A., Kiewiet, J. J., et al. (2011) Cost-effectiveness of ward-based pharmacy care in surgical patients: protocol of the SUREPILL (Surgery & Pharmacy In Liaison) study. BMC Health Services Research, 11, 55.
23. Classen, D. C. M., Lloyd, R. C. P., Provost, L. P., Griffin, F. A. R., &, Resar, R. M. D., (2008) Development and evaluation of the Institute for Healthcare Improvement Global Trigger Tool. Journal of Patient Safety, 4, 169-177.
24. Macedo, A. F., Marques, F. B., Ribeiro, C. F., &, Teixeira, F., (2003) Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. Journal of Clinical Pharmacy and Therapeutics, 28, 137-143.
25. Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., &, Greenblatt, D. J., (1981) A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics, 30, 239-245.
26. Takata, G. S., Mason, W., Taketomo, C., Logsdon, T., &, Sharek, P. J., (2008) Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals. Pediatrics, 121, 927-935.
27. Sharek, P. J., Horbar, J. D., Mason, W., Bisarya, H., Thurm, C. W., Suresh, G., Gray, E. L., Edwards, W. H., Goldmann, D., &, Classen, D., (2006) Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs. Pediatrics, 118, 1332-1340.
28. Cohen, J. A., (1960) Coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20, 37-46.
29. Fleiss, J. L., (1971) Measuring nominal scale agreement among many raters. Psychological Bulletin, 76, 378-382.
30. Sim, J., &, Wright, C. C., (2005) The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Physical Therapy, 85, 257-268.
31. Landis, J. R., &, Koch, G. G., (1977) An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics, 33, 363-374.
32. WHO Collaborating Centre for Drug Statistics Methodology Anatomical Therapeutic Chemical (ATC) classification system, 2012. Available at: http://www.whocc.no/ (last accessed March 2012).
33. Leendertse, A. J., Egberts, A. C. G., Stoker, L. J., &, van den Bemt, P. M. L. A., (2008) Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Archives of Internal Medicine, 168, 1890-1896.
34. Uppsala Monitoring Centre, Sweden WHO-UMC causality assessment, 2010. Available at: http://www.who-umc.org/ (last accessed April 2010).
35. Kramer, M. S., Leventhal, J. M., Hutchinson, T. A., &, Feinstein, A. R., (1979) An algorithm for the operational assessment of adverse drug reactions. The Journal of the American Medical Association, 242, 623-632.
36. Arimone, Y., Bégaud, B., Miremont-Salamé, G., Fourrier-Réglat, A., Molimard, M., Moore, N., &, Haramburu, F., (2006) A new method for assessing drug causation provided agreement with experts' judgment. Journal of Clinical Epidemiology, 59, 308-314.
37. National Cancer Institute, USA Common Terminology Criteria for Adverse Events (CTCAE). 2009. Available at: http://cancer.gov/ (last accessed April 2010).
38. National Coordinating Council for Medication Error Reporting and Prevention index (NCC MERP), The United States Pharmacopeia, USA, 2001. Available at: http://www.nccmerp.org/ (last accessed April 2010).
39. Morimoto, T., Sakuma, M., Matsui, K., Kuramoto, N., Toshiro, J., Murakami, J., Fukui, T., Saito, M., Hiraide, A., &, Bates, D. W., (2011) Incidence of adverse drug events and medication errors in Japan: the JADE study. Journal of General Internal Medicine, 26, 148-153.
40. Naessens, J. M., O'Byrne, T. J., Johnson, M. G., Vansuch, M. B., McGlone, C. M., &, Huddleston, J. M., (2010) Measuring hospital adverse events: assessing inter-rater reliability and trigger performance of the Global Trigger Tool. International Journal for Quality in Health Care, 22, 266-274.
41. Matlow, A. G., Cronin, C. M. G., Flintoft, V., Nijssen-Jordan, C., Fleming, M., Brady-Fryer, B., Hiltz, M. A., Orrbine, E., &, Baker, G. R., (2011) Description of the development and validation of the Canadian Paediatric Trigger Tool. Quality & Safety in Health Care, 20, 416-423.
42. Moore, C., Li, J., Hung, C.-C., Downs, J., &, Nebeker, J. R., (2009) Predictive value of alert triggers for identification of developing adverse drug events. Journal of Patient Safety, 5, 223-228.
43. Kaldjian, L. C., Jones, E. W., Wu, B. J., Forman-Hoffman, V. L., Levi, B. H., &, Rosenthal, G. E., (2008) Reporting medical errors to improve patient safety: a survey of physicians in teaching hospitals. Archives of Internal Medicine, 168, 40-46.
44. Kumpf, V. J., (2006) Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutrition in Clinical Practice, 21, 279-290.